Cytokinetics, Incorporated (NASDAQ:CYTK) People

Cytokinetics, Incorporated

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Wendall Wierenga
Other companies: Crinetics Pharmaceuticals, Inc. (Director · Since at least Jul 17, 2018); Concert Pharmaceuticals Inc (Director · Mar 13, 2014 – Jun 14, 2018 · Past); Apricus Biosciences Inc (Director · Mar 10, 2014 – Jan 4, 2018 · Past); Ocera Therapeutics Inc (Director · Dec 19, 2013 – Dec 11, 2017 · Past); Santarus Inc (EVP, R&D · Jun 20, 2011 – Jan 2, 2014 · Past); XenoPort Inc (Director · May 7, 2009 – Jul 5, 2016 · Past); Onyx Pharmaceuticals Inc (Director · Dec 15, 2008 – Oct 1, 2013 · Past)
Director · Since at least Feb 9, 2011
Santo J Costa
Other companies: Aquestive Therapeutics, Inc. (Director · Jul 24, 2018 – Jun 20, 2024 · Past); Osi Pharmaceuticals Inc (Director · Jun 14, 2006 – Jun 7, 2010 · Past); CV Therapeutics Inc (Director · Jun 6, 2006 – Apr 14, 2009 · Past); NPS Pharmaceuticals Inc (Director · Jan 17, 2006 – May 22, 2007 · Past)
Director · Nov 1, 2010 – May 15, 2024 · Past
Edward M. Kaye
Other companies: Avidity Biosciences, Inc (Director · Since at least Jun 11, 2020); Stoke Therapeutics, Inc. (Director · Since at least Jun 18, 2019); Sarepta Therapeutics, Inc. (Chair of Scientific Advisory Board · Apr 24, 2012 – Nov 4, 2026 · Past)
Director · Since at least May 18, 2016
James Daly
Other companies: Halozyme Therapeutics, Inc. (Director · Since Sep 30, 2026); Madrigal Pharmaceuticals, Inc. (Director · Since at least Jun 20, 2025); ACADIA Pharmaceuticals Inc. (Director · Since at least May 29, 2025)
Director · Since at least Aug 19, 2025
Robert E. Landry
Other companies: Theravance Biopharma, Inc. (Director · Since at least Nov 5, 2026); Zymeworks Inc. (Director · Since at least Aug 10, 2025); Regeneron Pharmaceuticals, Inc. (EVP Finance CFO · Mar 31, 2022 – Feb 2, 2024 · Past)
Director · Since at least Feb 10, 2025
Sung Lee
Other companies: Tango Therapeutics, Inc. (Executive Vice President and Chief Financial Officer, Cytokinetics · Since at least Jan 2, 2026); Vir Biotechnology, Inc. (EVP & Chief Financial Officer · Mar 27, 2023 – Mar 27, 2024 · Past); Sangamo Therapeutics, Inc. (EVP, Chief Financial Officer · Oct 31, 2019 – Nov 25, 2020 · Past)
EVP, Chief Financial Officer · Since at least Apr 26, 2024
Caryn Gordon McDowell
Other companies: Quince Therapeutics, Inc. (Chief Legal & Adm. Officer · May 5, 2020 – Jun 6, 2022 · Past); Revance Therapeutics, Inc. (SVP, GC & Secretary · May 1, 2018 – Feb 15, 2020 · Past)
GC & Chief Compliance Officer · May 18, 2016 – Feb 27, 2018 · Past
Peter S Roddy
Other companies: Filana Therapeutics, Inc. (Chief Financial Officer · May 1, 2010 – Apr 8, 2016 · Past); Aspira Women's Health Inc. (Director · Feb 18, 2010 – Mar 17, 2016 · Past)
SVP Finance & CAO · Feb 8, 2018 – Feb 27, 2018 · Past
Wendell Wierenga
Other companies: Crinetics Pharmaceuticals, Inc. (Director · Since at least Jun 18, 2026); Dermata Therapeutics, Inc. (Director · Since at least Aug 12, 2021)
Director · Since at least Oct 15, 2025
Bonnie Charpentier
Other companies: Genitope Corp (VP of Regulatory Affairs · Dec 31, 2005 – Apr 27, 2006 · Past)
SVP Regulatory & Compliance · Jan 2, 2014 – Feb 28, 2017 · Past
Brett A Pletcher
Other companies: Gilead Sciences, Inc. (EVP,Corp Affairs & Gen Counsel · May 9, 2018 – Jun 10, 2022 · Past)
EVP, Chief Legal Officer · Aug 13, 2024 – Aug 30, 2024 · Past
Fady I. Malik
Other companies: Rocket Pharmaceuticals, Inc. (Independent Director · Since at least Mar 10, 2022)
EVP, Research & Development · Since at least Jun 1, 2012
Jeff Hessekiel
Other companies: Exelixis, Inc. (EVP & General Counsel · May 15, 2025 – May 15, 2025 · Past)
Chief Legal & Admin Officer · Since at least Nov 13, 2025
Mark A Schlossberg
Other companies: Impax Laboratories Inc (SVP and General Counsel · Feb 26, 2018 – May 4, 2018 · Past)
SVP - Legal & General Counsel · Jan 14, 2019 – Mar 15, 2022 · Past
Andrew CallosEVP, Chief Commercial Officer · Since at least Mar 15, 2021
B. Lynne ParshallDirector · Since at least Sep 1, 2026
Bradley Paul MorganSVP Drug Discovery & Early Dev · Nov 16, 2015 – Aug 31, 2017 · Past
Ching JawSVP Finance & CFO · Jun 26, 2017 – Mar 6, 2023 · Past
Diane WeiserSVP, Corporate Affairs · Since at least Nov 3, 2026
Elisabeth A. SchniedersSVP, Business Development · Since at least Nov 5, 2026
Isaac CiechanoverEVP, Corporate Development & Chief Business Officer · Since at least Nov 5, 2026
John FaurescuSVP, Deputy General Counsel & Corporate Secretary · Since at least Nov 5, 2026
John T. HendersonDirector · Since at least Apr 15, 2025
Muna BhanjiDirector · Since at least May 27, 2026
Nancy J. WysenskiDirector · Since at least Apr 15, 2026
Robert A. HarringtonDirector · Since at least Apr 8, 2022
Robert I. BlumPresident & CEO, Director · Since at least Apr 1, 2026
Robert WongVP, Chief Accounting Officer · May 15, 2019 – Dec 3, 2024 · Past
Sandford D SmithDirector · Apr 1, 2022 – Jan 2, 2024 · Past
Stephen B. HeitnerSVP, Chief Medical Officer · Since at least Oct 12, 2026
Tricia OttavianiSVP, U.S. & Global Marketing and Operations · Since at least Nov 5, 2026